BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16433831)

  • 1. The progesterone-induced blocking factor modulates the balance of PKC and intracellular Ca.
    Kozma N; Halasz M; Palkovics T; Szekeres-Bartho J
    Am J Reprod Immunol; 2006 Feb; 55(2):122-9. PubMed ID: 16433831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progesterone-induced blocking factor activates STAT6 via binding to a novel IL-4 receptor.
    Kozma N; Halasz M; Polgar B; Poehlmann TG; Markert UR; Palkovics T; Keszei M; Par G; Kiss K; Szeberenyi J; Grama L; Szekeres-Bartho J
    J Immunol; 2006 Jan; 176(2):819-26. PubMed ID: 16393965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progesterone-induced blocking factor is hormonally regulated in human astrocytoma cells, and increases their growth through the IL-4R/JAK1/STAT6 pathway.
    González-Arenas A; Valadez-Cosmes P; Jiménez-Arellano C; López-Sánchez M; Camacho-Arroyo I
    J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt B():463-70. PubMed ID: 25218441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PIBF: the double edged sword. Pregnancy and tumor.
    Szekeres-Bartho J; Polgar B
    Am J Reprod Immunol; 2010 Aug; 64(2):77-86. PubMed ID: 20367622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine production by lymphocytes in pregnancy.
    Szereday L; Varga P; Szekeres-Bartho J
    Am J Reprod Immunol; 1997 Dec; 38(6):418-22. PubMed ID: 9412725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A progesterone-induced protein increases the synthesis of asymmetric antibodies.
    Kelemen K; Bognar I; Paal M; Szekeres-Bartho J
    Cell Immunol; 1996 Jan; 167(1):129-34. PubMed ID: 8548836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progesterone and non-specific immunologic mechanisms in pregnancy.
    Szekeres-Bartho J; Par G; Szereday L; Smart CY; Achatz I
    Am J Reprod Immunol; 1997 Sep; 38(3):176-82. PubMed ID: 9325489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progesterone-induced blocking factor (PIBF) modulates cytokine production by lymphocytes from women with recurrent miscarriage or preterm delivery.
    Raghupathy R; Al-Mutawa E; Al-Azemi M; Makhseed M; Azizieh F; Szekeres-Bartho J
    J Reprod Immunol; 2009 Jun; 80(1-2):91-9. PubMed ID: 19371956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production and characterization of a novel monoclonal antibody against progesterone-induced blocking factor (PIBF).
    Ivanova-Todorova E; Kyurkchiev DS; Nalbanski A; Timeva T; Shterev A; Kyurkchiev SD
    J Reprod Immunol; 2008 Jul; 78(2):94-101. PubMed ID: 18243332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progesterone-dependent immunomodulation.
    Szekeres-Bartho J; Polgar B; Kozma N; Miko E; Par G; Szereday L; Barakonyi A; Palkovics T; Papp O; Varga P
    Chem Immunol Allergy; 2005; 89():118-125. PubMed ID: 16129958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antiabortive effect of progesterone-induced blocking factor in mice is manifested by modulating NK activity.
    Szekeres-Bartho J; Par G; Dombay Gy; Smart YC; Volgyi Z
    Cell Immunol; 1997 May; 177(2):194-9. PubMed ID: 9178647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunological pregnancy protective effect of progesterone is manifested via controlling cytokine production.
    Szekeres-Bartho J; Faust Z; Varga P; Szereday L; Kelemen K
    Am J Reprod Immunol; 1996 Apr; 35(4):348-51. PubMed ID: 8739452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progesterone regulates IL12 expression in pregnancy lymphocytes by inhibiting phospholipase A2.
    Par G; Geli J; Kozma N; Varga P; Szekeres-Bartho J
    Am J Reprod Immunol; 2003 Jan; 49(1):1-5. PubMed ID: 12733588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Extracellular Vesicles and PIBF in Embryo-Maternal Immune-Interactions.
    Szekeres-Bartho J; Šućurović S; Mulac-Jeričević B
    Front Immunol; 2018; 9():2890. PubMed ID: 30619262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of progesterone-induced blocking factor in severe preeclampsia and its association with immune tolerance imbalance].
    Lin L; Huang Y; Yu Y; Yang Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 Jun; 35(6):848-51. PubMed ID: 26111683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular cloning and immunologic characterization of a novel cDNA coding for progesterone-induced blocking factor.
    Polgar B; Kispal G; Lachmann M; Paar C; Nagy E; Csere P; Miko E; Szereday L; Varga P; Szekeres-Bartho J
    J Immunol; 2003 Dec; 171(11):5956-63. PubMed ID: 14634107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progesterone-induced blocking factor inhibits degranulation of natural killer cells.
    Faust Z; Laskarin G; Rukavina D; Szekeres-Bartho J
    Am J Reprod Immunol; 1999 Aug; 42(2):71-5. PubMed ID: 10476687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered Immune Response and Implantation Failure in Progesterone-Induced Blocking Factor-Deficient Mice.
    Csabai T; Pallinger E; Kovacs AF; Miko E; Bognar Z; Szekeres-Bartho J
    Front Immunol; 2020; 11():349. PubMed ID: 32218780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dehydroepiandrosterone and metformin modulate progesterone-induced blocking factor (PIBF), cyclooxygenase 2 (COX2) and cytokines in early pregnant mice.
    Luchetti CG; Mikó E; Szekeres-Bartho J; Paz DA; Motta AB
    J Steroid Biochem Mol Biol; 2008 Sep; 111(3-5):200-7. PubMed ID: 18606228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress effect on progesterone-induced blocking factor (PIBF) binding to PIBF-receptor in lymphocytes.
    de la Haba C; Palacio JR; Palkovics T; Szekeres-Barthó J; Morros A; Martínez P
    Biochim Biophys Acta; 2014 Jan; 1838(1 Pt B):148-57. PubMed ID: 23954806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.